Sahin T, Ayasun R, Rizzo A, Guven D
Cancers (Basel). 2024; 16(21).
PMID: 39518127
PMC: 11545344.
DOI: 10.3390/cancers16213689.
Kashimura S, Sato M, Inagaki T, Kin M, Manabe R, Kusumoto S
Thorac Cancer. 2024; 15(28):2049-2060.
PMID: 39193939
PMC: 11444929.
DOI: 10.1111/1759-7714.15437.
Hayashi M, Yoshikawa T, Mizusawa J, Hato S, Iwasaki Y, Sasako M
J Gastrointest Cancer. 2024; 55(3):1125-1133.
PMID: 38703333
DOI: 10.1007/s12029-024-01061-3.
Sharma S, Mehta N, Sauer T, Rollins L, Dittmer D, Rooney C
Blood Adv. 2024; 8(13):3360-3371.
PMID: 38640255
PMC: 11255116.
DOI: 10.1182/bloodadvances.2023012183.
Montgomery K, Basha M, Nyholm L, Smith C, Ananiev G, Fedorov A
J Pediatr Hematol Oncol Nurs. 2024; 41(3):157-171.
PMID: 38588659
PMC: 11874514.
DOI: 10.1177/27527530231214544.
Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial.
Pacheco-Barcia V, Custodio-Cabello S, Carrasco-Valero F, Palka-Kotlowska M, Marino-Mendez A, Carmona-Bayonas A
World J Gastrointest Oncol. 2024; 16(2):386-397.
PMID: 38425396
PMC: 10900150.
DOI: 10.4251/wjgo.v16.i2.386.
Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.
Ye M, Huang A, Yuan B, Tan G, Ai J, Liu H
Eur Arch Otorhinolaryngol. 2024; 281(4):1971-1989.
PMID: 38315178
DOI: 10.1007/s00405-024-08474-7.
Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer.
Rocha Martins P, Morais K, Galdino N, Jacauna A, Paula S, Magalhaes W
Sci Rep. 2023; 13(1):22634.
PMID: 38114557
PMC: 10730812.
DOI: 10.1038/s41598-023-49441-2.
Function and clinical application of exosome-how to improve tumor immunotherapy?.
Qin S, Cao J, Ma X
Front Cell Dev Biol. 2023; 11:1228624.
PMID: 37670933
PMC: 10476872.
DOI: 10.3389/fcell.2023.1228624.
Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas.
Tao R, Huang R, Yang J, Wang J, Wang K
BMC Cancer. 2023; 23(1):692.
PMID: 37488496
PMC: 10364387.
DOI: 10.1186/s12885-023-10897-0.
Impact of Preoperative Nutritional Status on Long-term Survival in Patients With Stage I-III Colorectal Cancer.
Shibutani M, Kashiwagi S, Fukuoka T, Iseki Y, Kasashima H, Maeda K
In Vivo. 2023; 37(4):1765-1774.
PMID: 37369485
PMC: 10347952.
DOI: 10.21873/invivo.13265.
Effects of the interactions between platelets with other cells in tumor growth and progression.
Li Y, Wang H, Zhao Z, Yang Y, Meng Z, Qin L
Front Immunol. 2023; 14:1165989.
PMID: 37153586
PMC: 10158495.
DOI: 10.3389/fimmu.2023.1165989.
Megakaryocyte-Derived IL-8 Acts as a Paracrine Factor for Prostate Cancer Aggressiveness through CXCR2 Activation and Antagonistic AR Downregulation.
Dahal S, Chaudhary P, Jung Y, Kim J
Biomol Ther (Seoul). 2023; 31(2):210-218.
PMID: 36787954
PMC: 9970838.
DOI: 10.4062/biomolther.2023.005.
FeO Nanoparticles in Combination with 5-FU Exert Antitumor Effects Superior to Those of the Active Drug in a Colon Cancer Cell Model.
Genc S, Taghizadehghalehjoughi A, Yeni Y, Jafarizad A, Hacimuftuoglu A, Nikitovic D
Pharmaceutics. 2023; 15(1).
PMID: 36678874
PMC: 9865889.
DOI: 10.3390/pharmaceutics15010245.
A novel inflammation-nutrition biomarker score for predicting prognosis of patients with cancer: results from a multicenter study.
Xie H, Ruan G, Wei L, Zhang H, Zhang Q, Ge Y
BMC Cancer. 2022; 22(1):1311.
PMID: 36517779
PMC: 9749281.
DOI: 10.1186/s12885-022-10399-5.
Prognostic prediction by a novel integrative inflammatory and nutritional score based on least absolute shrinkage and selection operator in esophageal squamous cell carcinoma.
Feng J, Wang L, Yang X, Chen Q, Cheng X
Front Nutr. 2022; 9:966518.
PMID: 36438741
PMC: 9686353.
DOI: 10.3389/fnut.2022.966518.
Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer.
Mathebela P, Damane B, Mulaudzi T, Mkhize-Khwitshana Z, Gaudji G, Dlamini Z
Int J Mol Sci. 2022; 23(22).
PMID: 36430229
PMC: 9693604.
DOI: 10.3390/ijms232213750.
A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs.
Villarreal-Garcia V, Estupinan-Jimenez J, Vivas-Mejia P, Gonzalez-Villasana V, Vazquez-Guillen J, Resendez-Perez D
Front Oncol. 2022; 12:980694.
PMID: 36226048
PMC: 9548555.
DOI: 10.3389/fonc.2022.980694.
Interleukin-17A mRNA Expression is Associated with the Prognosis of Patients with Colorectal Cancer: A Pooled Meta-Analysis.
Yang W, Chen J, Liang H, Wu W
Turk J Gastroenterol. 2022; 33(12):995-1003.
PMID: 36098359
PMC: 9797711.
DOI: 10.5152/tjg.2022.211071.
Engineered exosomes for studies in tumor immunology.
Alptekin A, Parvin M, Chowdhury H, Rashid M, Arbab A
Immunol Rev. 2022; 312(1):76-102.
PMID: 35808839
PMC: 11044177.
DOI: 10.1111/imr.13107.
